FDA Import Refusal UPS-5233642-9/1/1 — Glaxosmithkline
The FDA refused shipment UPS-5233642-9/1/1 from Glaxosmithkline (United Kingdom) on May 22, 2014. The refused product falls under Drugs and Biologics — ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 22, 2014
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 60RAH18 ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC)
- Charges
- 75